- Home
- NMTC vs LSTA Comparison
NMTC vs LSTA Comparison
Compare NMTC & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMTC
- LSTA
- Stock Information
- Founded
- NMTC 2009
- LSTA 1980
- Country
- NMTC United States
- LSTA United States
- Employees
- NMTC N/A
- LSTA N/A
- Industry
- NMTC Medical/Dental Instruments
- LSTA Misc Health and Biotechnology Services
- Sector
- NMTC Health Care
- LSTA Health Care
- Exchange
- NMTC Nasdaq
- LSTA Nasdaq
- Market Cap
- NMTC 21.0M
- LSTA 24.2M
- IPO Year
- NMTC N/A
- LSTA N/A
- Fundamental
- Price
- NMTC $0.82
- LSTA $2.58
- Analyst Decision
- NMTC
- LSTA Strong Buy
- Analyst Count
- NMTC 0
- LSTA 1
- Target Price
- NMTC N/A
- LSTA $15.00
- AVG Volume (30 Days)
- NMTC 267.8K
- LSTA 19.6K
- Earning Date
- NMTC 12-17-2024
- LSTA 11-12-2024
- Dividend Yield
- NMTC N/A
- LSTA N/A
- EPS Growth
- NMTC N/A
- LSTA N/A
- EPS
- NMTC N/A
- LSTA N/A
- Revenue
- NMTC $3,453,003.00
- LSTA N/A
- Revenue This Year
- NMTC $109.53
- LSTA N/A
- Revenue Next Year
- NMTC $90.00
- LSTA N/A
- P/E Ratio
- NMTC N/A
- LSTA N/A
- Revenue Growth
- NMTC 1.33
- LSTA N/A
- 52 Week Low
- NMTC $0.55
- LSTA $2.19
- 52 Week High
- NMTC $1.72
- LSTA $3.83
- Technical
- Relative Strength Index (RSI)
- NMTC 58.26
- LSTA 41.13
- Support Level
- NMTC $0.68
- LSTA $2.48
- Resistance Level
- NMTC $0.97
- LSTA $2.77
- Average True Range (ATR)
- NMTC 0.11
- LSTA 0.19
- MACD
- NMTC 0.03
- LSTA -0.01
- Stochastic Oscillator
- NMTC 69.24
- LSTA 56.52
About NMTC NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.